Sartorius Albumedix Limited
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Albumedix Ltd. (to 2024)
6
Ending by 2030
Feb 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 25, 2026The maintenance fee for Albumin variants (US 10,329,340) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
- 1 fee due Mar 22, 2027The maintenance fee for Process for Preparing Particles of Proteinaceous Material (US 9,139,611) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.
- 1 fee due Jun 10, 2027The maintenance fee for Albumin variants (US 10,501,524) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
- 1 fee due Oct 28, 2027The maintenance fee for Albumin Variants and Conjugates (US 10,633,428) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,493,545 | Albumin variants and conjugates In force · High confidence | In force | High confidence | |
| US 11,555,061 | Albumin Variants and Conjugates In force · Low confidence | In force | Low confidence | |
| US 12,116,400 | Albumin Variants and Conjugates In force · Low confidence | In force | Low confidence | |
| US 8,748,380 | Albumin Variants In force · High confidence | In force | High confidence | |
| US 10,696,732 | Albumin Variants In force · Medium confidence | In force | Medium confidence | |
| US 9,139,611 | Process for Preparing Particles of Proteinaceous Material In force · High confidence | In force | High confidence | |
| US 9,403,898 | Method for purifying albumin In force · USPTO record | In force | USPTO record | |
| US 8,822,417 | Albumin Variants In force · High confidence | In force | High confidence | |
| US 10,844,349 | Albumin Formulation and Use In force · High confidence | In force | High confidence | |
| US 10,711,050 | Variant serum albumin with improved half-life and other properties In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.